Posters on the topic "Migraine"

The TRPA1 pain pathway is a target for multiple environmental pollutants: Possible relevance for migraine

Pharmacological characterization of gepants in human and porcine vasculature

Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial

A Phase 2/3 Open-label, Long-term, Safety Trial of Zavegepant 10 mg Nasal Spray for the Acute Treatment of Migraine

Sustained Response to Atogepant in Individuals with Episodic Migraine: Post Hoc Analyses of 12- and 52-Week Phase 3 Trials

Post-hoc Analysis Evaluating Safety of Atogepant in ADVANCE & Open-Label Extension Participants with Cardiovascular Risk Factors

Cut-off value for Tampa Scale for Kinesiophobia in migraine patients

A retrospective real-life multicenter study on concurrent oral preventives in patients with chronic migraine treated with botulinum toxin

Impact of Eptinezumab on Patient-Reported Outcomes in Patients With Prior Preventive Treatment Failures

Subsequent Response to Atogepant in Individuals with Episodic Migraine after an Initial Inadequate Response: Post Hoc Analysis of a 12-week Phase 3 Trial

Eptinezumab for Migraine Prevention in Patients with 2-4 Prior Treatment Failures: DELIVER Subpopulation Analysis

Efficacy and Safety of Eptinezumab for Migraine Prevention in Patients With 2–4 Prior Preventive Treatment Failures

Psychopathological disorders in chronic migraine: is there an association with the endocannabinoid system?

Real-World Persistence and Costs Among Patients With Chronic Migraine Treated With OnabotulinumtoxinA or CGRP mAbs: A Retrospective Claims Analysis Study

Rimegepant for the Acute Treatment of Migraine: Subgroup Analyses From 3 Phase 3 Clinical Trials by Triptan Treatment Experience

Adenosine causes short-lasting vasodilation and headache, but not migraine attacks in migraine patients: A randomized clinical trial

Treatment Responder Rates of Oral Atogepant for the Preventive Treatment of Chronic Migraine: Results From the PROGRESS Trial

Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: methods and global findings for diagnosis rates and care

Eptinezumab Improved Work Productivity in Adults With Migraine and Prior Preventive Treatment Failures: Results From the Randomized, Double-Blind, Placebo-Controlled DELIVER Study

Monthly Migraine Days, Acute Medication Use Days, and Migraine-Specific Quality of Life in Responders to Atogepant: A Post Hoc Analysis

Evaluation of PREEMPT fixed-dose, fixed-site and follow the pain treatment paradigms in the PREDICT Study

The virtual "Enfacement Illusion" on pain perception in patients suffering from chronic migraine: Preliminary data from a randomized controlled trial

Oral Rimegepant 75 mg is Safe and Well Tolerated in Adults With Migraine and Cardiovascular Risk Factors: Results of a Multicenter, Long-Term, Open-Label Safety Study

Medication Preference, Satisfaction, and Clinical Improvement Among Adults Receiving Long-Term Treatment With Rimegepant for Migraine

Characterizing gaps in preventive treatment of migraine: global results from the CaMEO-International study

Concomitant treatment of anti-CGRP and botulinum toxin in resistant migraine, is it useful for our patients?

The effect or resveratrol in ex vivo and behavioral rat models of migraine

Is migraine causally linked to inflammatory bowel disease or coeliac disease? A Mendelian randomisation study

Medication overuse and patient-reported outcome of OnabotulinumtoxinA treatment in Chronic Migraine

Atogepant for the Preventive Treatment of Chronic Migraine in Europe: Results From the PROGRESS Study

Additional effects of pain neuroscience education combined with physiotherapy on the headache frequency of adult patients with migraine – a randomized controlled trial

Assessing Hypersensitivity, Cortical Hyperexcitability, and Habituation in Migraine, according to Age and Disease Severity, using Visual Evoked Potentials during Pattern-Reversal Stimulation

Effects of vitamin B1, B6, and B12 on serum levels of CGRP, endothelial nitric-oxide synthase, homocysteine, and headache characteristics in women with episodic migraine

Quantifying aversion thresholds to light, sound, smell, and touch in migraine: A longitudinal study in migraine and non-headache controls

Negative impact of under-diagnosed migraine in university students in Slovakia

Change in Migraine Diagnosis After Preventive Treatment With Eptinezumab: Post Hoc Analysis of the PROMISE Studies

Hormonal treatment for menstrual migraine: rationale and protocol of the WHAT!-Trial

Efficacy and Safety of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial

Identification of crystal-clear days in migraine using data of a nation-wide population-based study

Long-Term Treatment With Lasmiditan in Patients With Migraine: Results From the Open-Label Extension of the CENTURION Study

Patterns of use of monoclonal antibodies for the preventive treatment of migraine: Results from the OVERCOME (EU) study

Cardiovascular risk factors and migraine: Results from the population-based Rotterdam study

A prospective evaluation of neurological presentations to a National Neuro-Behçet Clinic in the UK- Migraine is the commonest neurological complaint in Behçet's disease

Safety and tolerability of atogepant: a post hoc analysis of pooled data from four clinical trials

Effect of atogepant on Migraine-Specific Quality of Life Questionnaire and Headache Impact Test-6 in a 12-week, double-blind, randomized, phase 3 (PROGRESS) trial for preventive treatment of chronic migraine (CM)

Effect of atogepant on the Activity Impairment in Migraine–Diary and Work Productivity and Activity Impairment Questionnaire in a 12-week, double-blind, randomized, phase 3 (PROGRESS) trial for preventive treatment of chronic migraine (CM)

Erenumab as a first line preventive treatment for episodic migraine in Spain: a cost-effectiveness analysis.

Impact of migraine attack accompanying symptoms in treatment response to anti-CGRP monoclonal antibodies treatment and their evolution after 6 months

Mapping Migraine Minds: A cross-sectional survey to compare the difference in the level of treatment expectations and satisfaction for migraine among Indian male & female patients

Migraine, chronic neck pain and endurance muscle cervical test – a controlled study

Effects of Rimegepant 75 mg on Monthly Migraine Days: a 52-Week, Open-Label Extension Study

Safety and Tolerability of Rimegepant Every Other Day for Preventive Treatment of Migraine Plus As-Needed for Acute Treatment of Migraine: Results from A 52-Week, Open-Label Extension Study

Onabotulinum toxinA for unremitting chronic migraine: assessment of muscle function and strength, efficacy and safety after 10 years of continuous treatment.

Long-term Effectiveness and Safety of Erenumab in patients with Migraine: a Systematic Review and Single-Arm Meta-analysis

Prospective evaluation of migraine premonitory symptoms during the 30 days period

Prevalence of sinonasal symptoms in migraine without aura (results from Migraine in Poland - a nationwide cross-sectional survey)

Evaluation of a mandatory drug holiday during treatment with monoclonal antibodies targeting the cgrp pathway: a patient survey

Use of CGRP monoclonal antibodies and patient-reported improvement: Results from the OVERCOME (EU) study

Total tau concentrations are increased in blood serum of migraine patients: A cross-sectional case-control study

Disconnectome of the Migraine Brain: A Model of Migraine as "Connectopathy"

Changes in Sensitization and Habituation Measured by Algometry in Chronic Migraine Patients Treated with Onabotulinumtoxin A

Mapping Migraine Minds: A cross-sectional survey to compare the difference in burden of migraine among Indian male & female patients

Whole-brain functional connectome alterations in patients with migraine

Interictal IgE and tryptase levels in episodic and chronic migraine

Efficacy and safety of once monthly subcutaneous erenumab 70 mg in adult chronic migraine patients (primary analysis): Indian sub analysis from Global DRAGON study

Subjective Tinnitus in Pediatric and Adolescent Migraine Versus Other Primary Headaches – a Prospective, Comparative Study

Influence of Neck Pain in Response to Cervical Spine Manual Palpation on Neck Proprioception and Muscle Endurance of Migraine Patients and Controls

Association Between Migraine and Transient Global Amnesia: An Inpatient Sample Analysis

Gradually shifting clinical phenomics in migraine spectrum: A Cross-sectional, Multicenter study of 5438 patients

Characterization of the spectral content of resting-state electroencephalographic activity in chronic migraine female patients

Impact of air pollution exposure on headache onset in migraine patients

A Cohort Study Comparing Melatonin-users with Non-users in the treatment of Migraine Headaches.

Epilepsy in Migraine Aggravates the Cognitive Disorders

Impact of migraine in Indian housewives: A subset analysis from Mapping Migraine Minds study- A cross-sectional study to compare the difference in burden of migraine among Indian males & females

The effect of botulinum toxin on anxiety and depression scales in chronic and high frequency migraneurs

Intravenous lidocaine and ketamine infusions for headache disorders: a retrospective cohort study

HEADWORK as innovative tool for monitoring MABs efficacy in migraine and their influence on work activity.

Optimization of Acute Treatment in Migraine Patients Treated with Monoclonal Antibodies Acting on the CGRP Pathway

Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Real World Data from two Prospective Studies using a Digital Therapeutic

Iprazochrome and codeine – unlikely winners in migraine treatment in Poland. Targeting areas for improvement in migraine treatment (results from Migraine in Poland - a nationwide cross-sectional survey)

Alternative Indirect Treatment Comparisons for Eptinezumab in Migraine Prevention

Clinical pattern and response to treatment of predominant posterior migraine

Classification of the pain curve and semiology of a migraine crisis

Evolution of practice guidelines for the treatment of acute migraine with Paracetamol (Acetaminophen)

Craniocervical Flexion Test in patients with migraine: discriminatory validity and accuracy

Prevalence, disease profile, treatment patterns and burden of migraine in India: An internet-based survey

Use of Carbamazepine in Patients with Migraine-Comorbid Epilepsy in The Uzbek Population

Treatment of Migraine in children and adolescents

Vitamins and migraine? Is it a matter? The possible effects and suggested pathophysiology

Vestibular Migraine: Management differences between General Neurology and Neuro-Otology

Prediction of a migraine crisis in real-time using a wearable device

Utility of machine-learning based models to predict 30%, 50% and 75% response to anti-CGRP response in patients with migraine: a multicenter Spanish study

Machine prescription for chronic migraine

@TrialMigraine: A Daily Migraine Clinical Trials Tracker

Functional responses in a patient-specific iPSC-derived vascular model: a novel approach to study migraine

The structure and organization of headache differential diagnoses: A Pilot Study of Subset Relationships between Differentials in ICHD3

A comprehensive list of prevention medications without drug-drug interactions can be generated from DrugBank and FAERS

How to sequentially try all possible "pick two" combinations of abortive and/or prevention medications: an exploration in hamiltonian cycles in headache

Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcome

Sleep Disorders in Pediatric Migraine: a questionnaire-based study

Coexistence of migraine and cluster headache - is it more than just a coincidence?

Cutaneous allodynia in pediatric and adolescent patients and their mothers – a comparative study

Long-term effects of pandemic of Covid-19 on clinical features and psychological symptoms in adolescents with migraine

The influence of anxiety and depression on headache in adolescent migraineurs: A case-control study

Abnormal eye movements in a girl with Vestibular migraine: a case report and review of the literature

Allodynia and muscle sensitization of cervical muscles are not associated with neck range of motion in children and adolescents diagnosed with migraine

Does symptomatic treatment help children and adolescents with chronic migraine?

Angelman syndrome and cyclic vomiting syndrome: a new potential association – Not all the vomiting are only vomiting!

Clinical characteristics of children and adolescents with primary and secondary headaches in the tertiary-level of a public hospital in Brazil

Sars-Cov-2 and Headache in Children and adolescents

Prevalence of neck pain in migraine: A systematic review and meta-analysis

Characterizing opioid use in a Dutch cohort with migraine

The association of innate and adaptive immunity with migraine in The Rotterdam Study: a population-based cohort study

Visual aura in non-migrainous headache: a population study

Migraine Should Be First Focus on Headache Education in the Middle East, Asia, and Africa: A subgroup analysis of the Head-MENAA Study

Switching from anti-CGRP-receptor mAb (erenumab) to an anti-CGRP-molecule mAbs (fremanezumab) in chronic migraine: results of a real-world study

REAL-WORLD FREMANEZUMAB EXPERIENCE FROM HEADACHE CLINIC IN MOSCOW

Discontinuation after one-year of treatment with anti-CGRP antibodies did not provide long-term sustained response without therapy

Anti-CGRP monoclonal antibodies and peripheral sensitization: a study on Pressure Pain Threshold in migraineurs

Is it worth switching monoclonal antibodies?

Study on the presence of comorbidities in a series of 200 patients with migraine and their influence on the effectiveness of fremanezumab.

Predictors of galcanezumab response in Korean patients with migraine

Can We Descriminate Migraine Susceptibile to CGRP Antagonism?

Interim Analysis on the Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: The Observational PEARL Study

Response patterns in migraine patients in prophylactic treatment with different anti-CGRP pharmacological blockade systems

Effect of Galcanezumab in Migraine and Concomitant Medication Overuse Headache Without Prior Drug Withdrawal

Factors associated with favorable outcome in galcanezumab treatment for chronic migraine: A clinic-based prospective study

Past Preventive Migraine Treatment in Patients Initiating Fremanezumab in Clinical Practice: Interim Data from the PEARL Study

Descriptive study on the presence, treatment and evolution of comorbidities in a series of 200 migraine patients treated with fremanezumab.

Response to fremanezumab in migraine patients with and without prior aCGRP mAbs - preliminary data from the FINESSE study

Could Symptom Severity Predict the Response to Anti-Cgrp Monoclonal Antibodies in Migraine?

Prevalence of migraine according to Migraine Screening-Questionnaire (MS-Q) and headache characteristics in patients with inflammatory bowel disease (IBD)

Influence of migraine and migraine aura on the prescription of hormonal contraception in German outpatient gynecological clinics

Sex differences in migraine attack characteristics: a longitudinal E-diary study

Ketogenic diet for migraine prevention: an effective option beyond weight loss

Impact of migraine on the presentation of reversible cerebral vasoconstriction syndrome

Relevance of mouse vasculature in investigating side-effects of anti-migraine medications.

Characterization of adult patients with status migrainosus in a tertiary hospital in Colombia, 2019-2021

Implementing a digital treatment solution for headache patients – a pilot study.

Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model

PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine

Prevalence of temporomandibular disorders with comorbid migraine: A retrospective study in a 5-year period 

Neurovascular Orofacial Pain – A Diagnostic Dilemma

An open-source electrophysiology system to explore visual evoked potentials in migraine

Real-world Reductions in Monthly Migraine Days and Migraine-Related Healthcare Resource Utilization in UK Patients Using Fremanezumab

Anti-CGRP mAbs in a difficult to treat migraine population. Efficacy and safety.

The efficacy of CGRP monoclonal antibodies – an Australian experience

Use of non-pharmacological therapies in individuals with migraine eligible for treatment with monoclonal antibodies targeting calcitonin gene-related peptide (CGRP)-signaling: a single-center cross-sectional observational study

Role of Monoclonal Antibodies Against the Calcitonin Gene-Related Peptide or Receptor (CGRP-Mabs) for Chronic Migraine Prevention: A Critical Review

Real Life Experience: Use of CGRP Inhibitors in Patients Older than 55 Years Old, are they Safe and Effective?

Real life experience and learning curve of Galcanezumab in migraine. Galca-only Consortium

Investigating the Long-Term Efficacy of Calcitonin Gene Related Peptide Monoclonal Antibodies

Effects of caffeine on intracranial pressure and pain perception in freely moving rats

Diagnostic utility of T2*-weighted GRE in migraine with aura attack. The cortical veins sign

Emotional processing differences between migraine and tension-type headache subjects – an fMRI study

Dynamic functional connectivity in migraine during the interictal phase: a resting-state fMRI study

Reliable posterior insula–operculum region gray matter volume alterations in vestibular migraine

White-matter microstructural changes in episodic menstrual migraine compared with hormonal controls

Neuroimaging Utilization in Telemedicine Relative to In-Person Initial Visits for Migraine and Headache at a Tertiary Headache Center: A One-Year Analysis

Clinical manifestations and impact of SARS-CoV-2 infections and vaccines in patients with migraine

Effect of Covid 19 Infection on Episodic Migraine Patients in Saudi Populations and Role of Vaccination

Glibenclamide posttreatment does not inhibit levcromakalim induced headache: A randomized clinical trial

Recording pre-ictal migraine changes in cortical responsivity using EEG in a patient's home environment

Vestibular signs in experimentally induced migraine attacks: a post-hoc, exploratory analysis